company-creation
(7)
Canada Invents the Medicine. adMare Wants It to Own the Company, Too.
Canada has no shortage of good science. Its leak is what happens next. adMare puts capital, commercial judgment, lab benches and trained operators around discoveries so the companies - and more of their value - can stay home.
Polaris Partners Gets to Work Before There’s a Company
The Boston venture firm helps turn academic science into businesses. Its record shows why finding the money can be easier than finding a market.
The Factory for Ideas Big Companies Couldn’t Use
Innventure goes hunting in corporate R&D departments for technology that works but has nowhere to go. Then it tries to do the expensive part: turn the orphaned invention into an industrial business.
The Venture Firm That Bought a Hospital
General Catalyst spent 25 years turning startups into giants. Then it did something no venture firm had done before - it bought a hospital.
Redesign Health Turned Starting a Healthcare Company Into a Repeatable Process
The New York studio has launched more than 60 healthcare companies since 2018 by treating the messy work of starting one - ideas, diligence, hiring, capital - as a system you can run again and again.
Errik Anderson
Errik Anderson is the founder and CEO of Alloy Therapeutics, a Lexington, Massachusetts biotech he built around a single idea: stop selling drugs and start selling access to the tools that make them. A bioengineer and serial entrepreneur, he has founded or co-founded seven venture-backed biotech companies - Adimab, Alloy, Compass Therapeutics, Alector, Arsanis, and Avitide among them - whose technologies have helped discover more than 90 therapeutic antibodies now approved or in FDA review. Alloy reinvests 100% of its revenue into science and, by design, can never be sold. Outside the lab, Anderson co-owns the New England Free Jacks pro rugby team and has chaired Major League Rugby's Board of Governors.
Beckie Robertson
Beckie Robertson is co-founder and general partner at Versant Ventures, a San Francisco-based venture capital firm focused on biotechnology and drug discovery. A chemical engineer by training, she has spent decades backing early-stage medical device and diagnostics companies, with prior operating roles at Chiron Diagnostics, Lifescan, and Egis. She currently serves as vice chair of the Cornell Board of Trustees and was awarded the Cornell Duffield Engineering Distinguished Alumni Award in April 2026.